Efficacy and safety of 3-week response-guided triple direct-acting antiviral therapy for chronic hepatitis C infection: a phase 2, open-label, proof-of-concept study
Titel:
Efficacy and safety of 3-week response-guided triple direct-acting antiviral therapy for chronic hepatitis C infection: a phase 2, open-label, proof-of-concept study
Auteur:
Lau, George Benhamou, Yves Chen, Guofeng Li, Jin Shao, Qing Ji, Dong Li, Fan Li, Bing Liu, Jialiang Hou, Jinlin Sun, Jian Wang, Cheng Chen, Jing Wu, Vanessa Wong, April Wong, Chris L P Tsang, Stella T Y Wang, Yudong Bassit, Leda Tao, Sijia Jiang, Yong Hsiao, Hui-Mien Ke, Ruian Perelson, Alan S Schinazi, Raymond F